Twelve-month safety and performance results of the paclitaxel-eluting bioabsorbable magnesium scaffold in the prospective, multicenter first-in-man trial - BIOSOLVE-I

被引：0
|
作者：
Haude, M. [1 ]
Erbel, R. [2 ]
Verheye, S. [3 ]
Waksman, R. [4 ]
Degen, H. [1 ]
Boese, D. [2 ]
Vermeersch, P. [3 ]
Erne, P. [5 ]
Koolen, J. [6 ]
机构：
[1] Lukaskrankenhaus GmbH, Stadt Kliniken Neuss, Neuss, Germany
[2] W German Heart Ctr, Essen, Germany
[3] ZNA Middelheim, Antwerp, Belgium
[4] Washington Hosp Ctr, Medstar Res Inst, Washington, DC 20010 USA
[5] Luzerner Kantonsspital, Luzern, Switzerland
[6] Catharina Hosp, Dept Cardiol, Eindhoven, Netherlands
来源：
EUROPEAN HEART JOURNAL | 2012年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：840 / 840
页数：1
相关论文
共 27 条
  • [1] Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial
    Haude, Michael
    Erbel, Raimund
    Erne, Paul
    Verheye, Stefan
    Degen, Hubertus
    Boese, Dirk
    Vermeersch, Paul
    Wijnbergen, Inge
    Weissman, Neil
    Prati, Francesco
    Waksman, Ron
    Koolen, Jacques
    LANCET, 2013, 381 (9869): : 836 - 844
  • [2] Three-year clinical data of the BIOSOLVE-I Study with the paclitaxel-eluting bioabsorbable magnesium scaffold (DREAMS) and multi-modality imaging analysis
    Haude, Michael
    Erbel, Raimund
    Erne, Paul
    Verheye, Stefan
    Vermeersch, Paul
    Degen, Hubertus
    Boese, Dirk
    Waksman, Ron
    Weissman, Neil
    Prati, Francesco
    Koolen, Jacques
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (18) : B13 - B13
  • [3] Three-Year Clinical Data of the Biosolve-I Study With the Paclitaxel-Eluting Bioabsorbable Magnesium Scaffold (Dreams) and Multi-Modality Imaging Analysis
    Haude, Michael
    Erhel, Raimund
    Erne, Paul
    Verheye, Stefan
    Vermeersch, Paul
    Degen, Hubertus
    Boese, Dirk
    Waksmans, Ron
    Weissman, Neil
    Prati, Francesco
    Koolen, Jacques
    CIRCULATION, 2013, 128 (22)
  • [4] Three Year Clinical and Imaging Data of the Paclitaxel-Eluting Absorbable Magnesium Scaffold (Dreams) From the Biosolve-I Study
    Haude, Michael
    Erbel, Raimund
    Erne, Paul
    Verheye, Stefan
    Vermeersch, Paul
    Degen, Hubertus
    Bose, Dirk
    Waksman, Ron
    Weissman, Neil
    Prati, Francesco
    Koolen, Jacques
    CIRCULATION, 2014, 130
  • [5] Twelve-month results of a Paclitaxel Releasing Balloon in Patients Presenting with In-stent Restenosis First-in-Man (PEPPER) trial
    Hehrlein, Christoph
    Dietz, Ulrich
    Kubica, Jacek
    Jorgensen, Erik
    Hoffmann, Ellen
    Naber, Christoph
    Lesiak, Maciej
    Schneider, Henrik
    Wiemer, Marcus
    Toelg, Ralph
    Richardt, Gert
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2012, 13 (05) : 260 - 264
  • [6] Long term clinical data of the BIOSOLVE-I study with the paclitaxel-eluting absorbable magnesium scaffold (DREAMS) and multi-modality imaging analysis
    Haude, Michael
    Erbel, Raimund
    Erne, Paul
    Verheye, Stefan
    Vermeersch, Paul
    Degen, Hubertus
    Boese, Dirk
    Waksman, Ron
    Weissman, Neil
    Prati, Francesco
    Koolen, Jacques
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (11) : B182 - B183
  • [7] Safety and performance of the DRug-Eluting Absorbable Metal Scaffold (DREAMS) in patients with de novo coronary lesions: 3-year results of the prospective, multicentre, first-in- man BIOSOLVE-I trial
    Haude, Michael
    Erbel, Raimund
    Erne, Paul
    Verheye, Stefan
    Degen, Hubertus
    Vermeersch, Paul
    Weissman, Neil
    Prati, Francesco
    Bruining, Nico
    Waksman, Ron
    Koolen, Jacques
    EUROINTERVENTION, 2016, 12 (02) : E160 - E166
  • [8] Twelve-Month Results From the MAJESTIC Trial of the Eluvia Paclitaxel-Eluting Stent for Treatment of Obstructive Femoropopliteal Disease
    Mueller-Huelsbeck, Stefan
    Keirse, Koen
    Zeller, Thomas
    Schroe, Herman
    Diaz-Cartelle, Juan
    JOURNAL OF ENDOVASCULAR THERAPY, 2016, 23 (05) : 701 - 707
  • [9] Two-Year Clinical Data Of Cohort 1 And Multi-Modality Imaging Results Up To 1-Year Follow-Up Of The BIOSOLVE-I Study With The Paclitaxel-Eluting Bioabsorbable Magnesium Scaffold (DREAMS)
    Haude, Michael
    Erbel, Raimund
    Erne, Paul
    Verheye, Stefan
    Vermeersch, Paul
    Degen, Hubertus
    Boese, Dirk
    Waksman, Ron
    Weissman, Neil
    Prati, Francesco
    Koolen, Jacques
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (17) : B11 - B12
  • [10] Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial
    Haude, Michael
    Ince, Hueseyin
    Abizaid, Alexandre
    Toelg, Ralph
    Lemos, Pedro Alves
    von Birgelen, Clemens
    Christiansen, Evald Hoj
    Wijns, William
    Neumann, Franz-Josef
    Kaiser, Christoph
    Eeckhout, Eric
    Teik Lim, Soo
    Escaned, Javier
    Garcia-Garcia, Hector M.
    Waksman, Ron
    LANCET, 2016, 387 (10013): : 31 - 39
123